Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation.
Adolescent
Adult
Amino Acid Substitution
Child
Child, Preschool
Exons
Female
Gaucher Disease
/ genetics
Glucosylceramidase
/ chemistry
Humans
India
Infant
Infant, Newborn
Male
Models, Molecular
Mutation
Sequence Analysis, DNA
/ methods
Structural Homology, Protein
White People
/ genetics
Young Adult
Chitotriosidase
GBA1 gene
Gaucher disease
Glucocerebrosidase
Indian population
novel mutations in GBA1 gene
p.Leu483Pro most common mutation
β-Glucosidase
Journal
BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552
Informations de publication
Date de publication:
14 02 2019
14 02 2019
Historique:
received:
29
10
2018
accepted:
22
01
2019
entrez:
16
2
2019
pubmed:
16
2
2019
medline:
21
8
2019
Statut:
epublish
Résumé
Gaucher disease is a rare pan-ethnic, lysosomal storage disorder resulting due to beta-Glucosidase (GBA1) gene defect. This leads to the glucocerebrosidase enzyme deficiency and an increased accumulation of undegraded glycolipid glucocerebroside inside the cells' lysosomes. To date, nearly 460 mutations have been described in the GBA1 gene. With the aim to determine mutations spectrum and molecular pathology of Gaucher disease in India, the present study investigated one hundred unrelated patients (age range: 1 day to 31 years) having splenomegaly, with or without hepatomegaly, cytopenia and bone abnormality in some of the patients. The biochemical investigation for the plasma chitotriosidase enzyme activity and β-Glucosidase enzyme activity confirmed the Gaucher disease. The mutations were identified by screening the patients' whole GBA gene coding region using bidirectional Sanger sequencing. The biochemical analysis revealed a significant reduction in the β-Glucosidase activity in all patients. Sanger sequencing established 71 patients with homozygous mutation and 22 patients with compound heterozygous mutation in GBA1 gene. Lack of identification of mutations in three patients suggests the possibility of either large deletion/duplication or deep intronic variations in the GBA1 gene. In four cases, where the proband died due to confirmed Gaucher disease, the parents were found to be a carrier. Overall, the study identified 33 mutations in 100 patients that also covers four missense mutations (p.Ser136Leu, p.Leu279Val, p.Gly383Asp, p.Gly399Arg) not previously reported in Gaucher disease patients. The mutation p.Leu483Pro was identified as the most commonly occurring Gaucher disease mutation in the study (62% patients). The second common mutations identified were p.Arg535Cys (7% patients) and RecNcil (7% patients). Another complex mutation Complex C was identified in a compound heterozygous status (3% patients). The homology modeling of the novel mutations suggested the destabilization of the GBA protein structure due to conformational changes. The study reports four novel and 29 known mutations identified in the GBA1 gene in one-hundred Gaucher patients. The given study establishes p.Leu483Pro as the most prevalent mutation in the Indian patients with type 1 Gaucher disease that provide new insight into the molecular basis of Gaucher Disease in India.
Sections du résumé
BACKGROUND
Gaucher disease is a rare pan-ethnic, lysosomal storage disorder resulting due to beta-Glucosidase (GBA1) gene defect. This leads to the glucocerebrosidase enzyme deficiency and an increased accumulation of undegraded glycolipid glucocerebroside inside the cells' lysosomes. To date, nearly 460 mutations have been described in the GBA1 gene. With the aim to determine mutations spectrum and molecular pathology of Gaucher disease in India, the present study investigated one hundred unrelated patients (age range: 1 day to 31 years) having splenomegaly, with or without hepatomegaly, cytopenia and bone abnormality in some of the patients.
METHODS
The biochemical investigation for the plasma chitotriosidase enzyme activity and β-Glucosidase enzyme activity confirmed the Gaucher disease. The mutations were identified by screening the patients' whole GBA gene coding region using bidirectional Sanger sequencing.
RESULTS
The biochemical analysis revealed a significant reduction in the β-Glucosidase activity in all patients. Sanger sequencing established 71 patients with homozygous mutation and 22 patients with compound heterozygous mutation in GBA1 gene. Lack of identification of mutations in three patients suggests the possibility of either large deletion/duplication or deep intronic variations in the GBA1 gene. In four cases, where the proband died due to confirmed Gaucher disease, the parents were found to be a carrier. Overall, the study identified 33 mutations in 100 patients that also covers four missense mutations (p.Ser136Leu, p.Leu279Val, p.Gly383Asp, p.Gly399Arg) not previously reported in Gaucher disease patients. The mutation p.Leu483Pro was identified as the most commonly occurring Gaucher disease mutation in the study (62% patients). The second common mutations identified were p.Arg535Cys (7% patients) and RecNcil (7% patients). Another complex mutation Complex C was identified in a compound heterozygous status (3% patients). The homology modeling of the novel mutations suggested the destabilization of the GBA protein structure due to conformational changes.
CONCLUSIONS
The study reports four novel and 29 known mutations identified in the GBA1 gene in one-hundred Gaucher patients. The given study establishes p.Leu483Pro as the most prevalent mutation in the Indian patients with type 1 Gaucher disease that provide new insight into the molecular basis of Gaucher Disease in India.
Identifiants
pubmed: 30764785
doi: 10.1186/s12881-019-0759-1
pii: 10.1186/s12881-019-0759-1
pmc: PMC6376752
doi:
Substances chimiques
GBA protein, human
EC 3.2.1.45
Glucosylceramidase
EC 3.2.1.45
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
31Références
Am J Hum Genet. 2000 Jun;66(6):1777-86
pubmed: 10796875
Am J Hum Genet. 1993 Jun;52(6):1094-101
pubmed: 8503443
Orphanet J Rare Dis. 2012 Oct 09;7:77
pubmed: 23046562
Nucleic Acids Res. 1988 Feb 11;16(3):1215
pubmed: 3344216
Biochem J. 1965 Nov;97(2):17C-24C
pubmed: 16749131
J Biol Chem. 1994 Jan 21;269(3):2283-91
pubmed: 8294487
J Hum Genet. 2013 Sep;58(9):594-9
pubmed: 23719189
Indian J Pediatr. 2010 Feb;77(2):203-5
pubmed: 19936666
J Hum Genet. 2015 May;60(5):285
pubmed: 26008600
J Trop Pediatr. 2001 Apr;47(2):115-7
pubmed: 11336129
Hum Mol Genet. 2005 Aug 15;14(16):2387-98
pubmed: 16000318
Biochem Biophys Res Commun. 1965 Jan 18;18:221-5
pubmed: 14282020
N Engl J Med. 1987 Mar 5;316(10):570-5
pubmed: 2880291
Neurochem Res. 1999 Feb;24(2):207-11
pubmed: 9972866
Am J Hematol. 2012 Apr;87(4):377-83
pubmed: 22388998
J Hum Genet. 2007;52(5):391-396
pubmed: 17427031
Gene. 1990 Dec 15;96(2):277-83
pubmed: 2269438
Eur J Hum Genet. 2002 Sep;10(9):511-5
pubmed: 12173027
J Neurosci. 2016 Nov 16;36(46):11654-11670
pubmed: 27852774
Behav Brain Funct. 2012 Dec 10;8:57
pubmed: 23227814
BMC Med Genet. 2018 Oct 1;19(1):178
pubmed: 30285649
Genomics. 1989 Jan;4(1):87-96
pubmed: 2914709
Biochim Biophys Acta. 1968 Apr 24;159(1):141-6
pubmed: 5650428
Blood Cells Mol Dis. 2006 May-Jun;36(3):422-5
pubmed: 16546416
Eur J Med Genet. 2008 Jul-Aug;51(4):315-21
pubmed: 18586596
Hum Mutat. 2000;15(2):181-8
pubmed: 10649495
Am J Hum Genet. 1993 Oct;53(4):921-30
pubmed: 8213821
Braz J Med Biol Res. 2006 Sep;39(9):1171-9
pubmed: 16981045
Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):287-98
pubmed: 10744424
Hum Mutat. 1993;2(5):362-7
pubmed: 8257989
BMC Med Genet. 2018 May 11;19(1):76
pubmed: 29751744
Hum Mutat. 2008 May;29(5):567-83
pubmed: 18338393